Net Income

Alerus Financial is set to release its Q4 results, capping a year of strategic growth. Investors watch to see if its unique model can sustain momentum.

Earable Neuroscience partners with Tonino Lamborghini for a $1,999 brainband and joins the NSF's network, betting big on the new market of luxury cognitive tech.

A routine prenatal screen can now detect a virus that causes birth defects, offering a path to prevention and sparking calls to change medical guidelines.

With star hires and proprietary data analytics, Abacus Global Management is making an ambitious play for the booming asset-based finance sector.

As COO/CFO Ashim Gupta prepares for a key investor conference, UiPath aims to prove its 'agentic automation' strategy can deliver sustained growth.

With its first drug approved and a deep pipeline, all eyes are on Nuvation Bio's CEO David Hung at the upcoming J.P. Morgan Healthcare Conference.

With a $30.9M rights offering, Rare Element Resources aims to advance its Wyoming project, a key piece in America's race for rare earth independence.

LifeVantage heads to the ICR Conference to woo investors. Can its cellular health science overcome market headwinds and a volatile direct selling landscape?

Online education giant Stride, Inc. is embroiled in a legal battle over claims of inflated enrollment, systemic failures, and a 54% stock crash.

Finance software leader OneStream agrees to a $6.4B private equity buyout by Hg, aiming to fast-track its AI strategy less than two years after its IPO.

ASUS's new ExpertCenter Pro ET900N G3, powered by NVIDIA's Grace Blackwell Ultra, brings petaflop-scale AI power out of the data center and onto the desktop.

The executive search firm's record 2025 growth reveals how a blend of AI, data, and a unique business model is reshaping high-stakes talent acquisition.

Transcarent's WayFinding 2.0 moves beyond chat, using 'agentic AI' to schedule appointments, create health plans, and actively manage your care.

The first-ever Wegovy pill is here. Digital health firm eMed is partnering with Novo Nordisk to offer it, promising a new era of guided, responsible care.

A new nationwide study reveals a massive gap in care for heart failure patients, costing lives and billions. Why are proven, cheap medications being overlooked?

Aegis Aerospace and United Semiconductors are building a chip factory in space. This Texas-backed venture could revolutionize tech and national security.

The digital ad industry's standard-bearer unveils a plan to scale AI agents by upgrading existing protocols, aiming for interoperability over fragmentation.

UBC's strategic buyout of AI-specialist Evidinno signals a major shift in evidence generation, promising faster, smarter data solutions for biopharma.

By blending AI innovation with a 'whole person' wellness philosophy, MERGE sets a new standard for employee experience and industry leadership.

Facing declining revenue but armed with a strong AI vision, Unisys CEO Mike Thomson prepares to address investors at the critical Needham Growth Conference.